228 related articles for article (PubMed ID: 7737689)
61. The role of the invariant chain in mucosal immunity.
Barrera CA; Almanza RJ; Ogra PL; Reyes VE
Int Arch Allergy Immunol; 1998 Oct; 117(2):85-93. PubMed ID: 9784651
[TBL] [Abstract][Full Text] [Related]
62. Major histocompatibility complex class II-peptide complexes internalize using a clathrin- and dynamin-independent endocytosis pathway.
Walseng E; Bakke O; Roche PA
J Biol Chem; 2008 May; 283(21):14717-27. PubMed ID: 18378669
[TBL] [Abstract][Full Text] [Related]
63. Deletion of a C-terminal sequence of the class II-associated invariant chain abrogates invariant chains oligomer formation and class II antigen presentation.
Bertolino P; Staschewski M; Trescol-Biémont MC; Freisewinkel IM; Schenck K; Chrétien I; Forquet F; Gerlier D; Rabourdin-Combe C; Koch N
J Immunol; 1995 Jun; 154(11):5620-9. PubMed ID: 7751615
[TBL] [Abstract][Full Text] [Related]
64. In the absence of major histocompatibility complex class II molecules, invariant chain is translocated to late endocytic compartments by autophagy.
Chervonsky A; Sant AJ
Eur J Immunol; 1995 Apr; 25(4):911-8. PubMed ID: 7737293
[TBL] [Abstract][Full Text] [Related]
65. Transport and intracellular distribution of MHC class II molecules and associated invariant chain in normal and antigen-processing mutant cell lines.
Riberdy JM; Avva RR; Geuze HJ; Cresswell P
J Cell Biol; 1994 Jun; 125(6):1225-37. PubMed ID: 8207055
[TBL] [Abstract][Full Text] [Related]
66. Targeting major histocompatibility complex class II molecules to the cell surface by invariant chain allows antigen presentation upon recycling.
Nijenhuis M; Calafat J; Kuijpers KC; Janssen H; de Haas M; Nordeng TW; Bakke O; Neefjes JJ
Eur J Immunol; 1994 Apr; 24(4):873-83. PubMed ID: 8149958
[TBL] [Abstract][Full Text] [Related]
67. Antigen presentation by MHC class II molecules.
Weenink SM; Gautam AM
Immunol Cell Biol; 1997 Feb; 75(1):69-81. PubMed ID: 9046437
[TBL] [Abstract][Full Text] [Related]
68. MHC class II restricted antigen presentation.
Pieters J
Curr Opin Immunol; 1997 Feb; 9(1):89-96. PubMed ID: 9039772
[TBL] [Abstract][Full Text] [Related]
69. MHC class II antigen processing in B cells: accelerated intracellular targeting of antigens.
Cheng PC; Steele CR; Gu L; Song W; Pierce SK
J Immunol; 1999 Jun; 162(12):7171-80. PubMed ID: 10358163
[TBL] [Abstract][Full Text] [Related]
70. T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates.
Morkowski S; Goldrath AW; Eastman S; Ramachandra L; Freed DC; Whiteley P; Rudensky AYu
J Exp Med; 1995 Nov; 182(5):1403-13. PubMed ID: 7595211
[TBL] [Abstract][Full Text] [Related]
71. Intracellular transport of molecules engaged in the presentation of exogenous antigens.
Nordeng TW; Gorvel JP; Bakke O
Curr Top Microbiol Immunol; 1998; 232():179-215. PubMed ID: 9557399
[No Abstract] [Full Text] [Related]
72. Autophagy in MHC class II antigen processing.
Strawbridge AB; Blum JS
Curr Opin Immunol; 2007 Feb; 19(1):87-92. PubMed ID: 17129719
[TBL] [Abstract][Full Text] [Related]
73. Dendritic cells regulate exposure of MHC class II at their plasma membrane by oligoubiquitination.
van Niel G; Wubbolts R; Ten Broeke T; Buschow SI; Ossendorp FA; Melief CJ; Raposo G; van Balkom BW; Stoorvogel W
Immunity; 2006 Dec; 25(6):885-94. PubMed ID: 17174123
[TBL] [Abstract][Full Text] [Related]
74. Mutation of the invariant chain transmembrane region inhibits II degradation, prolongs association with MHC class II, and selectively disrupts antigen presentation.
Frauwirth K; Shastri N
Cell Immunol; 2001 May; 209(2):97-108. PubMed ID: 11446742
[TBL] [Abstract][Full Text] [Related]
75. Invariant chain, a chain of command.
Matza D; Kerem A; Shachar I
Trends Immunol; 2003 May; 24(5):264-8. PubMed ID: 12738421
[No Abstract] [Full Text] [Related]
76. CD1 trafficking: invariant chain gives a new twist to the tale.
Moody DB; Porcelli SA
Immunity; 2001 Dec; 15(6):861-5. PubMed ID: 11754808
[TBL] [Abstract][Full Text] [Related]
77. Intracellular transport of MHC class II molecules.
Neefjes JJ; Ploegh HL
Immunol Today; 1992 May; 13(5):179-84. PubMed ID: 1642756
[TBL] [Abstract][Full Text] [Related]
78. The cytoplasmic tail of invariant chain modulates antigen processing and presentation.
Gregers TF; Nordeng TW; Birkeland HC; Sandlie I; Bakke O
Eur J Immunol; 2003 Feb; 33(2):277-86. PubMed ID: 12548558
[TBL] [Abstract][Full Text] [Related]
79. Quality control of MHC class II associated peptides by HLA-DM/H2-M.
Vogt AB; Arndt SO; Hämmerling GJ; Kropshofer H
Semin Immunol; 1999 Dec; 11(6):391-403. PubMed ID: 10625593
[TBL] [Abstract][Full Text] [Related]
80. Assembly, Intracellular Transport, and Release of MHC Class II Peptide Receptors.
Temme S; Temme N; Koch N
Methods Mol Biol; 2019; 1988():297-314. PubMed ID: 31147949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
